[Myasthenic syndrome following oral treatment with penicillamine].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001763:Blepharoptosis / Q000139:chemically induced; D003680:Deglutition Disorders / Q000139:chemically induced; D004172:Diplopia / Q000139:chemically induced; D005260:Female; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000139:chemically induced*; D010396:Penicillamine / Q000009:adverse effects*
D010396:Penicillamine
Syndrome myasthénique après traitement peroral à la pénicillamine.